Mark Cuban Cost Plus Drug Company
PrivateLast Round
Seed
Jan 25, 2019
Total Funding Raised
$1.45M
Company Overview
Mark Cuban Cost Plus Drug Company is a public-benefit corporation that operates an online pharmacy and wholesale marketplace providing generic medications at transparent, low prices by bypassing traditional pharmacy benefit managers.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, E-commerce, D2C Brands
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mark Cuban Cost Plus Drug Company Comparables
Compare Mark Cuban Cost Plus Drug Company with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Honeybee Health | 88% | |
| DiRx | 86% | |
| ScriptCo Pharmacy | 83% | |
Mark Cuban Cost Plus Drug Company Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 25, 2019 | ||||
| Accelerator | Aug 22, 2018 |
Key People
Founding team and executive leadership
Mark Cuban Cost Plus Drug Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maveron | Accelerator, Seed |
| Asymmetry Ventures | Accelerator, Seed |
| Y Combinator | Seed, Accelerator |
| Lombardstreet Ventures | Accelerator, Seed |
| C3 Ventures | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Alliance with Alchem Laboratories Corp. to advance essential medicines.
- Dec 10, 2025
Developing direct-to-employer drug programs to bypass PBMs.
Mark Cuban Cost Plus Drug Company Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mark Cuban Cost Plus Drug Company's valuation, stock price, and market status.